• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用“库珀斯敦5+1鸡尾酒”对细胞色素P450 1A2、2C9、2C19、2D6和3A、N-乙酰转移酶-2以及黄嘌呤氧化酶活性进行联合表型评估。

Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5+1 cocktail".

作者信息

Chainuvati Siwaporn, Nafziger Anne N, Leeder J Steven, Gaedigk Andrea, Kearns Gregory L, Sellers Edward, Zhang Yanhua, Kashuba Angela D M, Rowland Elizabeth, Bertino Joseph S

机构信息

Department of Medicine, Bassett Healthcare, Cooperstown, NY 13326, USA.

出版信息

Clin Pharmacol Ther. 2003 Nov;74(5):437-47. doi: 10.1016/S0009-9236(03)00229-7.

DOI:10.1016/S0009-9236(03)00229-7
PMID:14586384
Abstract

Previously, we have validated a 4-drug phenotyping cocktail, the "Cooperstown cocktail," using caffeine (cytochrome p450 [CYP] 1A2, N-acetyltransferase-2 [NAT2], and xanthine oxidase [XO]), dextromethorphan (CYP2D6), omeprazole (CYP2C19), and intravenous midazolam (hepatic CYP3A). Data suggest that warfarin can be used as a safe and accurate biomarker for CYP2C9, and if warfarin is administered with vitamin K, the pharmacodynamic effect is ablated. Twelve subjects received the Cooperstown cocktail, warfarin plus vitamin K, and both sets of biomarkers (Cooperstown 5+1 cocktail) in a randomized crossover fashion. On the basis of log-transformed data and a paired t test, no significant difference was seen for S-warfarin area under the serum concentration-time curve from time 0 to infinity (P =.09), omeprazole metabolic ratio (P =.374), caffeine metabolic ratio (P =.169 for CYP1A2 activity), midazolam plasma clearance (P =.573), or dextromethorphan metabolic ratio (P =.747) with the Cooperstown cocktail, warfarin plus vitamin K alone, or the Cooperstown 5+1 cocktail. During drug administration, the only side effect was mild and short-lived sedation after intravenous midazolam administration. Phenotypic measurements were in concordance with the subject's CYP2C9, CYP2C19, and CYP2D6 genotypes. The Cooperstown 5+1 cocktail may be used to simultaneously assess the activities of CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A, NAT2, and XO.

摘要

此前,我们已验证了一种4种药物的表型分析鸡尾酒,即“库珀斯敦鸡尾酒”,它包含咖啡因(细胞色素P450 [CYP] 1A2、N - 乙酰转移酶 - 2 [NAT2]和黄嘌呤氧化酶[XO])、右美沙芬(CYP2D6)、奥美拉唑(CYP2C19)以及静脉注射咪达唑仑(肝脏CYP3A)。数据表明华法林可用作CYP2C9的安全且准确的生物标志物,并且如果华法林与维生素K一同给药,其药效学效应会被消除。12名受试者以随机交叉方式接受了库珀斯敦鸡尾酒、华法林加维生素K以及两组生物标志物(库珀斯敦5 + 1鸡尾酒)。基于对数转换数据和配对t检验,从时间0至无穷大的S - 华法林血清浓度 - 时间曲线下面积(P = 0.09)、奥美拉唑代谢率(P = 0.374)、咖啡因代谢率(CYP1A2活性,P = 0.169)、咪达唑仑血浆清除率(P = 0.573)或右美沙芬代谢率(P = 0.747)在单独使用库珀斯敦鸡尾酒、华法林加维生素K或库珀斯敦5 + 1鸡尾酒时均无显著差异。在给药期间,唯一的副作用是静脉注射咪达唑仑后出现的轻度且短暂的镇静作用。表型测量结果与受试者的CYP2C9、CYP2C19和CYP2D6基因型一致。库珀斯敦5 + 1鸡尾酒可用于同时评估CYP1A2、CYP2C9、CYP2C19、CYP2D6、CYP3A、NAT2和XO的活性。

相似文献

1
Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5+1 cocktail".使用“库珀斯敦5+1鸡尾酒”对细胞色素P450 1A2、2C9、2C19、2D6和3A、N-乙酰转移酶-2以及黄嘌呤氧化酶活性进行联合表型评估。
Clin Pharmacol Ther. 2003 Nov;74(5):437-47. doi: 10.1016/S0009-9236(03)00229-7.
2
Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".采用“库珀斯敦鸡尾酒”对细胞色素P450 1A2、细胞色素P450 2C19、细胞色素P450 2D6、细胞色素P450 3A、N-乙酰基转移酶-2和黄嘌呤氧化酶进行联合表型评估。
Clin Pharmacol Ther. 2000 Oct;68(4):375-83. doi: 10.1067/mcp.2000.109519.
3
Maribavir pharmacokinetics and the effects of multiple-dose maribavir on cytochrome P450 (CYP) 1A2, CYP 2C9, CYP 2C19, CYP 2D6, CYP 3A, N-acetyltransferase-2, and xanthine oxidase activities in healthy adults.马里巴韦的药代动力学以及多剂量马里巴韦对健康成年人细胞色素P450(CYP)1A2、CYP 2C9、CYP 2C19、CYP 2D6、CYP 3A、N - 乙酰转移酶 - 2和黄嘌呤氧化酶活性的影响。
Antimicrob Agents Chemother. 2006 Apr;50(4):1130-5. doi: 10.1128/AAC.50.4.1130-1135.2006.
4
Development of the "Inje cocktail" for high-throughput evaluation of five human cytochrome P450 isoforms in vivo.用于体内高通量评估五种人细胞色素P450同工酶的“Inje鸡尾酒”的开发。
Clin Pharmacol Ther. 2007 Nov;82(5):531-40. doi: 10.1038/sj.clpt.6100187. Epub 2007 Mar 28.
5
Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers.洛匹那韦/利托那韦可诱导细胞色素P450酶CYP2C9、CYP2C19和CYP1A2的肝脏活性,但在健康志愿者中,通过表型药物鸡尾酒检测发现,它会抑制CYP3A的肝脏和肠道活性。
J Acquir Immune Defic Syndr. 2006 May;42(1):52-60. doi: 10.1097/01.qai.0000219774.20174.64.
6
Effects of Upadacitinib Coadministration on the Pharmacokinetics of Sensitive Cytochrome P450 Probe Substrates: A Study With the Modified Cooperstown 5+1 Cocktail.乌帕替尼联合用药对敏感细胞色素 P450 探针底物药代动力学的影响:一项采用改良库珀斯敦 5+1 鸡尾酒的研究。
J Clin Pharmacol. 2020 Jan;60(1):86-95. doi: 10.1002/jcph.1496. Epub 2019 Aug 5.
7
Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method.使用创新型干血样采集方法对用于细胞色素P450表型分析的日内瓦鸡尾酒疗法中药物相互作用的评估。
Basic Clin Pharmacol Toxicol. 2016 Sep;119(3):284-90. doi: 10.1111/bcpt.12586. Epub 2016 Apr 25.
8
Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A.五种探针鸡尾酒用于 CYP1A2、2C9、2C19、2D6 和 3A 的药代动力学评估。
Br J Clin Pharmacol. 2009 Dec;68(6):928-35. doi: 10.1111/j.1365-2125.2009.03548.x.
9
Assessment of cytochrome P450 activity by a five-drug cocktail approach.采用五药鸡尾酒法评估细胞色素P450活性。
Clin Pharmacol Ther. 2001 Nov;70(5):455-61. doi: 10.1067/mcp.2001.119813.
10
Effect of a triphasic oral contraceptive on drug-metabolizing enzyme activity as measured by the validated Cooperstown 5+1 cocktail.通过经验证的库珀斯敦5+1组合药测定三相口服避孕药对药物代谢酶活性的影响。
J Clin Pharmacol. 2005 Dec;45(12):1413-21. doi: 10.1177/0091270005280851.

引用本文的文献

1
The Use of Microdosing for In vivo Phenotyping of Cytochrome P450 Enzymes: Where Do We Stand? A Narrative Review.微量给药在细胞色素 P450 酶体内表型研究中的应用:我们处于什么位置? 一篇叙述性综述。
Eur J Drug Metab Pharmacokinet. 2024 Jul;49(4):407-418. doi: 10.1007/s13318-024-00896-2. Epub 2024 Apr 30.
2
Effect of Daridorexant on the Pharmacokinetics of Midazolam, and on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Male Subjects.达利西坦对健康男性受试者中咪达唑仑药代动力学以及华法林药代动力学和药效学的影响。
Drugs R D. 2024 Mar;24(1):97-108. doi: 10.1007/s40268-024-00456-8. Epub 2024 Mar 13.
3
Single-cell metabolic profiling reveals subgroups of primary human hepatocytes with heterogeneous responses to drug challenge.
单细胞代谢组学揭示了原发性人肝细胞对药物挑战具有异质性反应的亚群。
Genome Biol. 2023 Oct 17;24(1):234. doi: 10.1186/s13059-023-03075-9.
4
Critical Assessment of Phenotyping Cocktails for Clinical Use in an African Context.非洲背景下临床使用的表型鸡尾酒的批判性评估。
J Pers Med. 2023 Jul 5;13(7):1098. doi: 10.3390/jpm13071098.
5
Phenotyping Indices of CYP450 and P-Glycoprotein in Human Volunteers and in Patients Treated with Painkillers or Psychotropic Drugs.人类志愿者以及服用止痛药或精神药物患者中CYP450和P-糖蛋白的表型分析指标
Pharmaceutics. 2023 Mar 18;15(3):979. doi: 10.3390/pharmaceutics15030979.
6
Assessment of the drug-drug interaction potential for therapeutic proteins with pro-inflammatory activities.评估具有促炎活性的治疗性蛋白的药物-药物相互作用潜力。
Clin Transl Sci. 2023 Jun;16(6):922-936. doi: 10.1111/cts.13507. Epub 2023 Apr 23.
7
Pharmacokinetic-Interactions of BI 425809, a Novel Glycine Transporter 1 Inhibitor, With Cytochrome P450 and P-Glycoprotein Substrates: Findings From In Vitro Analyses and an Open-Label, Single-Sequence Phase I Study.新型甘氨酸转运蛋白 1 抑制剂 BI 425809 的药代动力学相互作用与细胞色素 P450 和 P-糖蛋白底物:来自体外分析和一项开放标签、单序列 I 期研究的结果。
J Clin Psychopharmacol. 2023;43(2):113-121. doi: 10.1097/JCP.0000000000001656. Epub 2023 Jan 26.
8
Clinical Pharmacokinetics and Pharmacodynamics of Rucaparib.鲁卡帕尼的临床药代动力学和药效学。
Clin Pharmacokinet. 2022 Nov;61(11):1477-1493. doi: 10.1007/s40262-022-01157-8. Epub 2022 Sep 15.
9
Physiologically-based pharmacokinetic modeling of dextromethorphan to investigate interindividual variability within CYP2D6 activity score groups.基于生理的右美沙芬药代动力学模型研究 CYP2D6 活性评分组内个体间变异性。
CPT Pharmacometrics Syst Pharmacol. 2022 Apr;11(4):494-511. doi: 10.1002/psp4.12776. Epub 2022 Mar 8.
10
Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates: a phase I, multicenter, drug-drug interaction study in patients with ALK + advanced tumors.色瑞替尼对合并用药的 CYP3A 和 2C9 底物药代动力学的影响:一项在 ALK+晚期肿瘤患者中进行的 I 期、多中心药物相互作用研究。
Cancer Chemother Pharmacol. 2021 Apr;87(4):475-486. doi: 10.1007/s00280-020-04180-3. Epub 2021 Jan 4.